|
Market Closed -
Nasdaq
21:00:00 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.400 USD | +1.69% |
|
+6.67% | -55.31% |
Company Valuation: Compass Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 309 | 633.5 | 198.8 | 199.5 | 955.1 | 432.2 | - | - |
| Change | - | 105.02% | -68.61% | 0.34% | 378.75% | -54.75% | - | - |
| Enterprise Value (EV) 1 | 309 | 633.5 | 198.8 | 72.78 | 955.1 | 282.2 | 299.2 | 316.2 |
| Change | - | 105.02% | -68.61% | -63.39% | 1,212.3% | -70.45% | 6.02% | 5.68% |
| P/E | -2.42x | -13.6x | -4.73x | -4.03x | -12.8x | -4.79x | -4.34x | -11x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.2x | 0.4x | -0.44x | -0.8x | -0.2x | -0.4x | 0.2x |
| Capitalization / Revenue | - | - | - | 235x | - | - | 19.3x | 3.46x |
| EV / Revenue | - | - | - | 85.6x | - | - | 13.4x | 2.53x |
| EV / EBITDA | -3.8x | -15.5x | -4x | -1.3x | -13.2x | -2.82x | -2.8x | -3.08x |
| EV / EBIT | -3.77x | -15.2x | -3.95x | -1.29x | -13.1x | -2.84x | -2.7x | -6.54x |
| EV / FCF | -14.3x | - | - | -1.62x | -19.4x | -3.55x | -3.08x | -8.39x |
| FCF Yield | -6.98% | - | - | -61.7% | -5.15% | -28.2% | -32.5% | -11.9% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.31 | -0.37 | -0.33 | -0.36 | -0.42 | -0.5007 | -0.5529 | -0.2185 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | 0.85 | - | - | 22.39 | 124.7 |
| EBITDA 1 | -81.32 | -40.87 | -49.66 | -56.04 | -72.56 | -100.2 | -107 | -102.6 |
| EBIT 1 | -81.88 | -41.66 | -50.36 | -56.62 | -72.84 | -99.4 | -110.9 | -48.37 |
| Net income 1 | -82.18 | -39.22 | -42.49 | -49.38 | -66.49 | -94.04 | -109.8 | -45.82 |
| Net Debt 1 | - | - | - | -126.7 | - | -150 | -133 | -116 |
| Reference price 2 | 3.170 | 5.030 | 1.560 | 1.450 | 5.370 | 2.400 | 2.400 | 2.400 |
| Nbr of stocks (in thousands) | 97,472 | 125,938 | 127,455 | 137,589 | 177,862 | 180,088 | - | - |
| Announcement Date | 18/03/22 | 15/03/23 | 21/03/24 | 27/02/25 | 05/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.79x | - | -2.82x | - | 432M | |
| 21.45x | 7.54x | 15.37x | 1.38% | 72.12B | |
| 37.53x | 9.72x | 29.82x | 0.04% | 65.85B | |
| -18.08x | 7.59x | -9.85x | -.--% | 29.28B | |
| -79.5x | 14.86x | -71.64x | -.--% | 27.47B | |
| 33.76x | 6.66x | 17.64x | -.--% | 26.7B | |
| 27.2x | 5.1x | 17.12x | -.--% | 20.06B | |
| 52.91x | 19.58x | 39.65x | 0.29% | 18.22B | |
| 2460.33x | 41.28x | -5047.29x | -.--% | 16.4B | |
| 16.73x | 4.96x | 11.58x | -.--% | 13.4B | |
| Average | 254.75x | 13.03x | -500.04x | 0.19% | 28.99B | |
| Weighted average by Cap. | 152.77x | 11.04x | -276.90x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CMPX Stock
- Valuation Compass Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
